RAC 2.92% $1.94 race oncology ltd

Ann: Breakthrough Zantrene Heart Protection Discovery, page-126

  1. 6,742 Posts.
    lightbulb Created with Sketch. 1712

    Great question and response! This is the kind of de-risking an investor seeks.

    Dr.T, how does this translate to Keytruda and other drugs not included in this trial? Thanks.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.